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Abstract
Background: The viable yellow allele of agouti (A
vy) is remarkable for its unstable and partially heritable epigenetic state,
which produces wide variation in phenotypes of isogenic mice. In the A
vy allele an inserted intracisternal A particle (IAP) acts
as a controlling element which deregulates expression of agouti by transcription from the LTR of the IAP; the phenotypic
state has been linked to CpG methylation of the LTR. Phenotypic variation between A
vy mice indicates that the epigenetic
state of the IAP is unstable in the germline.
Principal Findings: We have made a detailed examination of somatic methylation of the IAP using bisulphite allelic
sequencing, and find that the promoter is incompletely methylated even when it is transcriptionally silent. In utero exposure
to supplementary methyl donors, which alters the spectrum of A
vy phenotypes, does not increase the density of CpG
methylation in the silent LTR.
Conclusions: Our findings suggest that, contrary to previous supposition, methyl donor supplementation acts through an
indirect mechanism to silence A
vy. The incomplete cytosine methylation we observe at the somatically silent A
vy allele may
reflect its unstable germline state, and the influence of epigenetic modifications underlying CpG methylation.
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Introduction
Retroelements, genomic parasites that amplify via reverse
transcription of their RNA and re-insertion into the host genome,
make up a large proportion of the DNA of mammalian species
[1,2,3]. Insertion of retroelements can disrupt genomic structure in
several ways [4,5], but can also disrupt gene regulation [6]. While
most retroelements have accumulated mutations that make them
unable to retrotranspose, a very large number probably retain
intact promoters which, when active, can interfere with transcrip-
tion of genes in their vicinity [1,6,7]. Retroelements are generally
maintained in a silent epigenetic state, and carry dense CpG
methylation; epigenetic suppression of retroelements is a key
function of CpG methylation in vertebrates [8,9].
Retroelements may escape epigenetic silencing and interfere
with transcription of neighbouring genes. An example is the
intracisternal A-particle (IAP) retrotransposon responsible for the
murine agouti viable yellow alleles, including the A
vy allele that is
the subject of this study. In the viable yellow alleles of agouti,a n
IAP is inserted upstream of agouti (a different site in each allele) and
exhibits a strong propensity for transcriptional activity: it is active
in a high proportion of A
vy mice and frequently reverts in the
germline from methylated and silent to unmethylated and active
[10,11,12,13,14,15,16].
The labile epigenetic state of the A
vy IAP results in extremely
variable penetrance of the associated phenotype in isogenic mice
[13,14]. When the IAP is active, a cryptic promoter in its 59 LTR
usurps transcriptional control of agouti and drives ectopic
expression of the agouti signalling protein (ASP) [11]. Pancellular
expression of ASP produces a neomorphic phenotype of yellow
fur, obesity, Type II diabetes, and predisposition to tumors [15].
When the IAP is silent, agouti is expressed in its normal hair cycle-
specific pattern, giving the wild-type agouti coat colour (called
pseudoagouti). The variable activity of the IAP results in a
spectrum of phenotypes from fully yellow and obese, through
degrees of variegated yellow/agouti with intermediate body mass,
to lean pseudoagouti (Figure 1A). A
vy mice always produce
offspring with a range of phenotypes, indicating that the epigenetic
state of the allele is unstable in the germline [13,15]. Maternal
phenotype does however influence the phenotype of offspring
(paternal phenotype does not), consistent with weak inheritance of
the epigenetic state through the female germline [13,15].
The A
vy phenotype appears to correlate with cytosine methyl-
ation of the 59LTR of the IAP: in pseudoagouti mice the LTR is
methylated, in yellow mice it is unmethylated, and in mottled mice
methylation is intermediate [13,17,18,19]. Dietary supplementa-
tion of pregnant dams with methyl donor molecules shifts the
phenotype of A
vy offspring towards pseudoagouti, and this effect
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e9055Figure 1. Phenotypic variation in A
vy mice, A
vy allele structure, and complex CpG methylation at the IAP. A. Phenotypes of isogenic A
vy
littermates range from pure yellow and obese (left) through mottled yellow/agouti to lean fully agouti, called pseudoagouti (right). B. Schematic of
the A
vy locus, with the sequence of the amplified region, which includes portions of the 59LTR and pseudoexon 1A (2240 to +92 relative to the
cryptic promoter, which is marked by an arrow). The start point of A
vy transcription [11] is marked by an arrow. CpG dinucleotides are displayed in red.
C. Representative bisulphite allelic sequencing profiles of individual alleles from yellow and pseudoagouti mice. Each single row represents a single
allele, and each box a CpG (white: unmethylated; black: methylated).
doi:10.1371/journal.pone.0009055.g001
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[17,20]. However, none of these analyses have used methods
which provide allelic patterns of methylation at A
vy, so detailed
knowledge of A
vy methylation patterns is lacking.
We have used bisulphite allelic sequencing to assess cytosine
methylation in the IAP at A
vy, and in three similar IAPs selected
from the mouse genome. We find that the relationship between
activity state and methylation state at the A
vy allele is not the simple
‘‘all-or-none’’ pattern that has been supposed on the basis of less
detailed methylation analyses. The silent A
vy IAP is incompletely
methylated in comparison to the three other IAPs, and we
speculate that this is related to its germline epigenetic lability.
Maternal methyl donor supplementation did not increase the
density of cytosine methylation on the silent A
vy IAP. Our results
highlight the complex nature of epigenetic regulation at A
vy and
support a view of cytosine methylation as a secondary mark of
epigenetic silence at A
vy.
Results
Cytosine Methylation at A
vy in Yellow and Pseudoagouti
Mice
Previous investigations have linked the activity state of the A
vy
allele with CpG methylation of the 59LTR of the inserted IAP,
where ectopic transcription of agouti is initiated [13,17,18,19].
Results have suggested that in yellow mice the allele is
unmethylated, in pseudoagouti mice it is methylated, and in
mottled mice the methylation is intermediate; consistent results
have been obtained with two other viable yellow alleles [10,12].
The evidence is derived from Southern blot analysis with
methylation-specific restriction enzymes [10,12,13,17], and from
sequencing of PCR products amplified from bisulphite-treated
DNA in the region of the cryptic promoter in the 59 LTR [18] or
the adjacent pseudoexon 1A [19]. These methods do not provide
information on allelic methylation patterns, but instead give an
average of methylation on all alleles in the sample population.
Studies that have used bisulphite allelic sequencing have not
examined the relationship between phenotype and methylation
pattern [21,22]. To analyse allelic patterns of methylation at A
vy,
we performed bisulphite allelic sequencing [23] of the A
vy IAP
59LTR on tail DNA from yellow and pseudoagouti mice. In this
method, each sequence is derived from an individual allele in the
tissue from which the DNA was extracted. By sequencing large
numbers of alleles, and displaying them together, a picture of
epiallelic variation in an individual or tissue can be assembled.
As expected,we foundthat obeseyellowmice(inwhich activity of
the IAP is pancellular) had almost no methylation at A
vy (Figure 1C).
On the basis of the worknoted above, and muchevidence that CpG
hypermethylation is characteristic of silent retroelements, we
expected that pseudoagouti mice would display the opposite
pattern: dense CpG methylation. Instead we found that CpG
methylation of the IAP in pseudoagouti mice is incomplete
(Figure 1C). Very few alleles had methylation of all CpGs in the
amplicon, and some alleles did not carry any methylation at all. An
average of 66% of CpGs were methylated across all A
vy alleles from
pseudoagouti mice. This result was surprising because previous
studies examining other silent IAPs had indicated much heavier
methylation density at silent LTRs [22,24,25].
The Silent A
vy IAP Is Incompletely Methylated
Dense cytosine methylation is a characteristic feature of
vertebrate retroelements, and is linked to their transcriptional
silence [8]; thus the incomplete methylation of the silent A
vy IAP
would seem to be highly unusual. Another highly unusual feature
of the A
vy IAP is its germline epigenetic instability: from one
generation to the next, the phenotype is only weakly stable with
maternal transmission and completely unstable with paternal
transmission [13,14]. We supposed that incomplete methylation of
the A
vy IAP might be related to its germline epigenetic lability. We
compared the methylation density in this element with other IAPs
in A
vy mice, which do not appear to show epigenetic variation.
We chose from the mouse genome database three IAPs of the
same class (ID1) as the A
vy IAP, here denoted as ‘‘A’’, ‘‘B’’ and ‘‘C’’.
(see Methods for details on these elements). Southern blotting of
these IAPs with methylation-specific restriction enzymes indicated
that they are consistently methylated in A
vy mice of all phenotypes
(data not shown). We studied the pattern and density of CpG
methylation in the 59LTRs of these elements with bisulphite allelic
sequencing, and compared it with methylation at the A
vy IAP.
All three of the selected IAPs displayed significantly more CpG
methylation in their 59LTRs than did the pseudoagouti (silent) A
vy
IAP (Figure 2A). IAP A was the most densely methylated, and
IAPs B and C displayed an intermediate methylation density
which was still heavier than the methylation at the silent A
vy IAP.
In each of the four IAPs methylation density displayed a normal
distribution around the mean percent methylation (Figure 2B), but
in IAPs A, B and C the mean percent methylation is higher. These
results support the view that methylation of the A
vy IAP is relatively
incomplete even when it is silent.
Maternal Methyl-Donor Supplementation Does Not
Increase Methylation Density in the Silent A
vy IAP
Dietary supplementation with methyl donors stabilizes the silent
state of the A
vy allele. When pregnant dams are fed a diet
supplemented with methyl donors, the proportion of pseudoagouti
offspring rises [17,19,26,27]. The effect persists into the next
generation even when supplementation is carried out only during
midgestation, indicating that the methyl donors have affected the
germline epigenetic state of A
vy [27]. It has been proposed that
methyl donors act on the A
vy allele by increasing methylation of the
IAP [17,19,26]. As discussed above, we supposed that the
incomplete methylation we observed at silent A
vy alleles might be
related to its unstable epigenetic state in the germline. We thus
asked if the increase in germline epigenetic stability observed after
methyl donor supplementation is accompanied by an increase in
the density of methylation at the silent A
vy.
We used bisulphite allelic sequencing to assess CpG methylation
of the A
vy IAP in pseudoagouti mice that had been supplemented in
utero with methyl donors (choline, betaine, L-methionine, zinc, folic
acid, and vitamin B12; see Methods), and in their unsupplemented
pseudoagouti offspring. These were compared with methylation
densities in mice that had never received supplementation (and
were not descended from supplemented mice). We analysed three
mice from each group and pooled the results.
We found that methyl donor supplementation did not increase
the density of CpG methylation at the silent A
vy allele; in fact
overall methylation was slightly reduced in comparison to
unsupplemented controls (Figure 3). Although this result does
not answer our question regarding whether cytosine methylation is
directly related to germline stability of A
vy, it may shed light on the
molecular mechanism of A
vy silencing by methyl donors, as the
result is inconsistent with the view that methyl donors act in some
direct way to increase CpG methylation.
Discussion
We have carried out a detailed investigation of the methylation
state of the IAP retrotransposon that acts as a controlling element
CpG Methylation of A
vy
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vy allele, with unexpected results that give insights into
epigenetic regulation at this allele. When compared with silent
IAPs that are closely related, the IAP in A
vy is incompletely
methylated when it is silent (in pseudoagouti mice); this may be a
reflection of an unusual germline epigenetic state.
The A
vy IAP is a ‘‘controlling element’’ in the sense the term was
used by McClintock, Brink, and others: a transposable element
that controls expression of a gene near its insertion site [7].
Controlling elements may be a common feature of higher
eukaryotes [6,28]. Individual A
vy mice exhibit high variation in
phenotype because the epigenetic state of the IAP is mosaic, and
when the IAP is active it transcribes the agouti gene (without any
apparent tissue specificity) [11,15,29]. This IAP is unusual among
retrotransposons: its epigenetic state is not only somatically
mosaic, but highly unstable in the germline. The phenotype of
individual A
vy mice seems to be determined early in embryogenesis
and maintained thereafter, indicating that in somatic cells the
epigenetic state is stable. Although germline inheritance of the
epigenetic state of A
vy has been established, the inheritance is weak
[13]. All of this is consistent with a tendency for epigenetic marks
Figure 2. Incomplete CpG methylation of the silent A
vy IAP. A. Bisulphite allelic sequencing profiles at the A
vy IAP and three other IAPs. Each
line represents an allele, and each box a CpG dinucleotide (white: unmethylated; black: methylated). Each block represents sequences derived from a
single mouse. B. Histograms of allelic CpG methylation density. Each histogram displays the frequency of alleles with a given number of CpGs
methylated across the sequenced region. For IAP C, only 10 CpGs were sequenced. n=number of alleles sequenced; *p,0.001.
doi:10.1371/journal.pone.0009055.g002
CpG Methylation of A
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vy allele to fluctuate in the
germline.
The incomplete CpG methylation of the IAP in the A
vy allele is
further evidence of its unusual epigenetic state. IAPs and
retrotransposons are almost invariably silent; extensive evidence
shows that they are heavily methylated, except during differenti-
ation of primordial germ cells and in the preimplantation embryo,
where partial or complete demethylation may occur [8]. We find
that the A
vy IAP, even when it is silent (i.e. in pseudoagouti mice), is
significantly less methylated than other closely related IAPs. We
speculate that there is a relationship between the incomplete
methylation of the A
vy IAP and its germline epigenetic instability:
the instability could be caused by the low density of cytosine
methylation at A
vy, or conversely, the incomplete methylation
could be reflective of an underlying unstable epigenetic state.
We and others have shown that supplementation of the
maternal diet with methyl donors can shift the spectrum of A
vy
phenotypes toward pseudoagouti [17,19,26,27]; we have recently
shown that this effect occurs only when the allele is paternally
derived, and that it can alter the germline epigenetic state of A
vy to
produce heritable effects on phenotype [27]. We hypothesised that
the stabilising effect of methyl donor supplementation on the silent
A
vy allele would involve an increase in methylation density, but the
findings presented here demonstrate that it did not. It should be
noted however that the stabilising effect of methyl donors is not
large: the shift in phenotypes towards pseudoagouti is subtle
[17,19,26,27]. It may be that germline silencing of A
vy would have
to be very stable before an observable increase in DNA
methylation occurred.
However, the fact that CpG methylation at the silent A
vy did not
increase in response to methyl donors may provide insight into the
mechanism by which methyl donors alter the spectrum of
phenotypes in A
vy mice. Methyl donors contribute to the pool of
S-adenosylmethionine, which can donate a methyl group to
proteins and to cytosine [26]. Previous studies showed that the
phenotypic shift induced by methyl donors is accompanied by an
increase in CpG methylation at the A
vy allele within the
supplemented population: this has been interpreted as indicating
that the effect of methyl donors is to directly increase methylation
at A
vy and thereby change the phenotype [17,19]. But the effect of
dietary methyl donors could also be mediated by an indirect
mechanism, for example by histone modifications [30,31] in the
region of the A
vy allele, resulting in a shift to epigenetic silence. The
observed increase in cytosine methylation would thus be due to
methylation of the already silenced allele. Our finding favors this
latter possibility: the amount of cytosine methylation at the silent
A
vy allele is not increased in response to methyl donor
supplementation, arguing against a direct effect on CpG
methylation. If methyl donors were to act directly on cytosine
methylation, one would expect to observe an increase in
methylation density not only over the population of supplemented
mice as a whole, but also at the extremes: that is, supplemented
pseudoagouti mice would show more methylation than pseudoa-
gouti mice that had not been supplemented. Our data show that
this is not the case, and suggest that methyl donors silence A
vy
through some pathway other than CpG methylation.
Our findings highlight the complex epigenetics of A
vy, and the
unusual behaviour of the IAP retrotransposon in this allele. What
might distinguish the IAP in the A
vy allele from other retro-
elements? The A
vy IAP is a relatively recent insertion, arising ,45
years ago. We propose that most retroelements, once they have
inserted into the host genome, undergo a gradual acquisition of
suppressive epigenetic marks in the germline; these marks likely
include multiple histone modifications as well as CpG methylation
and the binding of chromatin proteins. Eventually this accumu-
lation of marks results in a permanently silent state, one that is
retained through the mammalian life cycle and is resistant to
perturbations such as embryonic demethylation. The process may
be similar to the progressive germline silencing observed in some
mouse transgenes: the transgenes initially display variable but
declining activity, and eventually reach a silent state that is stable
for generations; somatic methylation of the transgene is evident
only when it has begun the process of germline silencing. One
implication of this model is that almost half of the mammalian
genome (retroelements) exists in a permanently silent state like that
of constitutive heterochromatin; the presence of this material may
contribute to the apparently spontaneous occurrence of germline
epimutations [32,33,34,35] because silent chromatin is known to
spread and silence adjacent euchromatin.
Is the A
vy IAP ever likely to become deeply silent and heavily
methylated? The relatively short time that the IAP has been
present at A
vy may not be sufficient for a retrotransposon to be
Figure 3. Disruption of cytosine methylation at the silent A
vy
allele by methyl-donor supplementation. The histograms display
the frequency of alleles with a given number of CpGs methylated across
the sequenced region in unsupplemented mice (top), mice exposed to
methyl-donor supplementation in utero (middle) and unsupplemented
offspring of supplemented mice (bottom). Each histogram represents
combined bisulphite allelic sequencing data from three pseudoagouti
mice. The red line shows the pattern of normal distribution. The
average percent methylation over all sequenced CpGs for each mouse
group is indicated. *p=0.037.
doi:10.1371/journal.pone.0009055.g003
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selection for the active state of the IAP, because the obese yellow
phenotype that is the result of IAP activity was for most of this time
the trait of interest, and the epigenetic basis of the phenotypic
variation was not at first understood [36,37]. It may be that the A
vy
allele is a case in which a recently inserted retrotransposon,
capable of transcriptional activity, has been maintained in an
active state by artificial selection for that state.
The incomplete methylation of A
vy may thus reflect its germline
epigenetic instability. The finding that methylation state of the IAP
does not precisely correlate with its activity is further evidence that
in somatic cells CpG methylation is a reflection of other epigenetic
factors that control the transcription state.
Materials and Methods
Mice and Diets
All animals were handled in strict accordance with good
practice as defined by the Office of Laboratory Animal Welfare
(NIH, USA), the NHMRC (Australia) Statement on Animal
Experimentation, and the requirements of NSW State Govern-
ment legislation. All animal work was approved by the CHORI
IACUC (Assurance number A3631-01) and the St Vincents/
Garvan Animal Ethics Committee (REFS: AEC#06/12;
AEC#09/12). The A
vy allele arose in the C3H/HeJ strain [36],
and was backcrossed into C57BL/6 at the Jackson Laboratory.
The mice used in this study are descended from the isogenic
C57BL/6 A
vy colony maintained at Oak Ridge National
Laboratories and were rederived at the VCCRI in 2001. Methyl
donor supplementation was carried out as previously described
[27]. Mice were fed ad libitum on NIH-31 diet (control) or methyl-
donor supplemented NIH-31 (plus (per kg) 15 g choline, 15 g
betaine, 7.5 g L-methionine, 150 mg zinc, 15 mg folic acid,
1.5 mg vitamin B12) (Specialty Feeds, Glen Forrest, WA, Australia)
[17,26]. Methyl-donor supplementation was started on day 8.5 of
gestation and discontinued at day 15.5. Female pseudoagouti (F1)
offspring of supplemented mice were bred to produce the F2
generation. Control groups were made up of mice bred in exactly
the same way but without any methyl-donor supplementation.
Retrotransposon Sequences
The sequence of the A
vy IAP was provided by Hugh Morgan,
University of Sydney, Australia. IAPs ‘‘A’’, ‘‘B’’ and ‘‘C’’ were
chosen by searching the mouse genome for sequences similar to
the A
vy IAP 59LTR. The 59LTR of IAP A has 88% sequence
identity with the A
vy IAP LTR and is found on chromosome 10 at
(59) 70,254,133-70,254,485 (39). The IAP B 59LTR has 87%
identity with the A
vy IAP LTR and is found on chromosome X at
(59) 70,187,292-70,187,643 (39) in intron 3 of the nsdhl gene. The
IAP C [24] 59LTR has 96% identity with the A
vy IAP LTR over its
59 244 bp (the region analysed in this study) and is divergent at the
39 150 bp; it is found on chromosome 2 at (59) 154179999-
154180392 (39), in intron 6 of the Cdk5rap1 gene.
Bisulphite Treatment and Methylation Sequencing of
IAPs
DNA was extracted from mouse tail tips. DNA was extracted by
digestion with Proteinase K and purification with phenol/
chloroform. 2 mg DNA was treated with sodium bisulphite as
described elsewhere [38,39]. The bisulphite-treated DNA was
resuspended in 50 ml water and 5 ml was used in PCR. The
primers used to amplify the 59LTRs were: A
vy IAP: gtagaggtttaag-
gatttagattggtg (fwd), aacccacaaaaccaaaatcttctac (rev) (primers
targeted (-) DNA strand); IAP A: tttatggggttagagtgtaagaagtaag
(fwd), caaattaccctattataacaaatatatctc (rev); IAP B: gtgaaygttagt-
tyggttattgggttg (fwd), cttacacctttaaaaactaaataacaaatcc (rev); IAP C:
gtatatagttaataagtgggtaatggtg (fwd), caaccattacctaaaacacatcactc
(rev). PCR products were cloned into pGEM-T and transformed
into E.coli, and plasmid DNA from individual colonies was
sequenced.
Statistical Analysis
Methylation data was analysed at the level of individual alleles,
so that the number of degrees of freedom relates to the number of
alleles sequenced (ANOVA was used to confirm that the
methylation levels of individual alleles were independent of the
mouse from which the alleles derived). Statistical significance was
tested using the Student’s t-test with a=0.05.
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